Although more detailed mechanisms contributing to the arsenite-induced inhibition of t-PA synthesis via the NRF2 pathway are not yet clear, inhibition of the fibrinolytic activity of t-PA by arsenite may be related to the progression of cardiovascular disease, including atherosclerosis, and microvascular disease. Here, NFE2L2 is linked to cardiovascular disorder.